Fostemsavir and Triptorelin: Interaction Details
- Fostemsavir
- Rukobia
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fostemsavir and Triptorelin interaction:
Triptorelin
We don't have a drug information page for Triptorelin yet. Have a question about Triptorelin? Ask a pharmacist, free →
What Happens When You Take Fostemsavir With Triptorelin
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Fostemsavir should be coadministered with caution alongside any drug that carries a known risk of torsade de pointes, since the combination may raise the risk of torsade de pointes.1
The Fostemsavir and Triptorelin Interaction, Explained
Fostemsavir (Rukobia) is an HIV medicine, and triptorelin is a hormone-blocking medicine often used for prostate cancer or other hormone-related conditions. Both can affect the heart's electrical rhythm in a small way, called . Taking them together could add up and, in rare cases, lead to a serious rhythm problem called .
This concern is mostly theoretical, meaning it is based on how the drugs work rather than on many real-world cases. Please keep taking both as prescribed. Let your pharmacist or doctor know about any heart problems or other medicines you take, and tell them right away if you feel faint, dizzy, or notice a racing or fluttering heartbeat. Your care team can keep an eye on this.
Mechanism: (). Fostemsavir (via its active moiety temsavir) has been associated with QTc prolongation at supratherapeutic exposures, and triptorelin (GnRH , androgen deprivation) is associated with QT prolongation and risk. Neither drug's effect depends on the other's , so this is not a interaction.
- Effect: increased risk of torsade de pointes
- Severity/evidence: major rating, theoretical evidence, onset unspecified
- Management: use caution with . Consider baseline and follow-up , and correct electrolytes (K, Mg). Review other QT-prolonging drugs and risk factors (structural heart disease, , congenital long QT).
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fostemsavir and Triptorelin Interact
The likely mechanism
How to Manage the Fostemsavir and Triptorelin Interaction
Your care team can manage this combination, typically with caution and closer attention to heart rhythm risk.
- Keep taking both medicines as prescribed unless your doctor or pharmacist tells you otherwise.
- Your team may monitor you more closely, which may include checking your heart rhythm, and may individualize your care based on your health.
- Tell them about any heart conditions, a family history of rhythm problems, and all other medicines or supplements you take.
- Report fainting, dizziness, or a pounding or irregular heartbeat right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fostemsavir or Triptorelin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Fostemsavir and Triptorelin: Common Questions
How serious is the Fostemsavir and Triptorelin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fostemsavir and Triptorelin interaction managed?
Your care team can manage this combination, typically with caution and closer attention to heart rhythm risk. Keep taking both medicines as prescribed unless your doctor or pharmacist tells you otherwise. Your team may monitor you more closely, which may include checking your heart rhythm, and may individualize your care based on your health. Tell them about any heart conditions, a family history… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Fostemsavir and Triptorelin Interaction
Ask in your own words about taking Fostemsavir and Triptorelin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: RUKOBIA oral extended-release tablets, fostemsavir oral extended-release tablets. ViiV Healthcare (per FDA), Durham, NC, 2024. DailyMed
Other Serious Interactions of Fostemsavir and Triptorelin
Also serious with Fostemsavir
- ApalutamideContraindicated
- CarbamazepineContraindicated
- DronedaroneContraindicated
- ElagolixContraindicated
Also serious with Triptorelin
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.